These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2573213

  • 41. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.
    Senior R, Basu S, Kinsey C, Schaeffer S, Lahiri A.
    Am Heart J; 1999 Apr; 137(4 Pt 1):646-52. PubMed ID: 10097224
    [Abstract] [Full Text] [Related]

  • 42. Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r.
    van der Does R, Eberhardt R, Derr I, Ehmer B, Rudorf J, Uberbacher HJ.
    Eur Heart J; 1991 Jan; 12(1):60-4. PubMed ID: 2009895
    [Abstract] [Full Text] [Related]

  • 43. Effects of carvedilol on ventricular arrhythmias.
    Senior R, Müller-Beckmann B, DasGupta P, van der Does R, Lahiri A.
    J Cardiovasc Pharmacol; 1992 Jan; 19 Suppl 1():S117-21. PubMed ID: 1378137
    [Abstract] [Full Text] [Related]

  • 44. Haemodynamic dose-response actions of cicloprolol in left ventricular dysfunction due to ischaemic heart disease.
    Silke B, Verma SP, Sharma SK, Baig W, Jackson NC, Reynolds G, Frais MA, Taylor SH.
    Int J Cardiol; 1987 Nov; 17(2):127-36. PubMed ID: 2890589
    [Abstract] [Full Text] [Related]

  • 45. Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise.
    Omvik P, Lund-Johansen P, Myking O.
    J Cardiovasc Pharmacol; 1992 Nov; 19 Suppl 1():S90-6. PubMed ID: 1378157
    [Abstract] [Full Text] [Related]

  • 46. Can intravenous beta blockade predict long-term haemodynamic benefit in chronic congestive heart failure secondary to ischaemic heart disease? A comparison between intravenous and oral carvedilol.
    DasGupta P, Lahiri A.
    Clin Investig; 1992 Nov; 70 Suppl 1():S98-104. PubMed ID: 1350492
    [Abstract] [Full Text] [Related]

  • 47. Carvedilol (Kredex) reduces infarct size in a canine model of acute myocardial infarction.
    Hamburger SA, Barone FC, Feuerstein GZ, Ruffolo RR.
    Pharmacology; 1991 Nov; 43(3):113-20. PubMed ID: 1685569
    [Abstract] [Full Text] [Related]

  • 48. Effectiveness of three different doses of carvedilol for exertional angina. Carvedilol-Angina Study Group.
    Weiss R, Ferry D, Pickering E, Smith LK, Dennish G, Krug-Gourley S, Lukas MA.
    Am J Cardiol; 1998 Oct 15; 82(8):927-31. PubMed ID: 9794346
    [Abstract] [Full Text] [Related]

  • 49. Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
    Shapiro W, Park J, DiBianco R, Singh SN, Katz RJ, Fletcher R.
    Chest; 1981 Oct 15; 80(4):425-30. PubMed ID: 6791883
    [Abstract] [Full Text] [Related]

  • 50. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
    Silke B, Verma SP, Frais MA, Reynolds G, Taylor SH.
    Br J Clin Pharmacol; 1986 Dec 15; 22(6):697-706. PubMed ID: 2882772
    [Abstract] [Full Text] [Related]

  • 51. Acute hemodynamic effects of bufuralol: a beta-adrenoceptor blocking drug with vasodilatory effects.
    Pfisterer M, Burckhardt D, Bühler FR, Burkart F.
    J Cardiovasc Pharmacol; 1984 Dec 15; 6(3):417-22. PubMed ID: 6202966
    [Abstract] [Full Text] [Related]

  • 52. Effect of bisoprolol on exercise tolerance in patients with coronary heart disease: placebo-controlled double-blind crossover study.
    Schnellbacher K, Marsovszky E, Roskamm H.
    J Cardiovasc Pharmacol; 1986 Dec 15; 8 Suppl 11():S143-7. PubMed ID: 2439786
    [Abstract] [Full Text] [Related]

  • 53. Cardioprotective potential of carvedilol.
    Ruffolo RR, Bril A, Feuerstein GZ.
    Cardiology; 1993 Dec 15; 82 Suppl 3():24-8. PubMed ID: 8106160
    [Abstract] [Full Text] [Related]

  • 54. The efficacy and safety of dilevalol in patients with chronic stable angina pectoris.
    Glasser SP, Bittar N, Kinhal V, Bennett WT, Koehn DK.
    J Clin Pharmacol; 1989 Nov 15; 29(11):983-8. PubMed ID: 2574729
    [Abstract] [Full Text] [Related]

  • 55. Bisoprolol in the treatment of angina pectoris: a double blind comparison with verapamil.
    De Divitiis O, Liguori V, Di Somma S, Brignoli M, Ferraro S, Petitto M, Fazio S, Marsullo G, Salvatore M, Gradnik R.
    Eur Heart J; 1987 Dec 15; 8 Suppl M():43-54. PubMed ID: 2967185
    [Abstract] [Full Text] [Related]

  • 56. [Clinical and hemodynamic effects of anaprilin and carvedilol in patients with coronary heart disease].
    Vasil'ev AP, Strel'tsova NN, Gorbunova TIu, Dubova TV.
    Klin Med (Mosk); 2001 Dec 15; 79(12):13-6. PubMed ID: 11840802
    [Abstract] [Full Text] [Related]

  • 57. Antihypertensive treatment in concomitant peripheral vascular disease: current experience and the potential of carvedilol.
    Breckenridge A, Roberts DH.
    J Cardiovasc Pharmacol; 1991 Dec 15; 18 Suppl 4():S78-81. PubMed ID: 1721985
    [Abstract] [Full Text] [Related]

  • 58. Celiprolol in the treatment of exercise induced angina pectoris.
    Capone P, Mayol R.
    J Cardiovasc Pharmacol; 1986 Dec 15; 8 Suppl 4():S135-7. PubMed ID: 2427844
    [Abstract] [Full Text] [Related]

  • 59. Acebutolol and left ventricular function: assessment by radionuclide angiography.
    Katz RJ, DiBianco R, Singh S, Bortz R, Bates HR, Sauerbrunn B, Laddu AR, Fletcher RD.
    Clin Pharmacol Ther; 1981 Feb 15; 29(2):149-54. PubMed ID: 7460480
    [Abstract] [Full Text] [Related]

  • 60. The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
    Simon H, Schuppan U.
    Arzneimittelforschung; 1983 Feb 15; 33(2a):318-21. PubMed ID: 6340700
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.